Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report_133_treasury_shares_espi.pdfNotification for sale of treasury shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 133 / 2026
Date of issue: 2026-05-08
Short name of the issuer
SOPHARMA AD
Subject
Notification for sale of treasury shares
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, May 08, 2026 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on May 07, 2026 the Company sold 145 000 (one hundred forty-five thousand) treasury shares representing 0.03% of the share capital of the Company, at a total value of EUR 257 965.01 on the Bulgarian Stock Exchange, the average price per share was EUR 1.78.
The total number of treasury shares after this transaction is 10 178 000 representing 1.89% of the share capital of the Company.
Annexes
File Description
Current report_133_treasury_shares_espi.pdf
Current report_133_treasury_shares_espi.pdf		 Notification for sale of treasury shares

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-05-08 Ognian Donev Executive Director
20260508_122509_0650682858_Current_report_133_treasury_shares_espi.pdf

Pobierz